Cargando…
Tuberculosis in migrants – screening, surveillance and ethics
Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473829/ https://www.ncbi.nlm.nih.gov/pubmed/32923311 http://dx.doi.org/10.1186/s41479-020-00072-5 |
_version_ | 1783579243390697472 |
---|---|
author | Scandurra, Gabriella Degeling, Chris Douglas, Paul Dobler, Claudia C. Marais, Ben |
author_facet | Scandurra, Gabriella Degeling, Chris Douglas, Paul Dobler, Claudia C. Marais, Ben |
author_sort | Scandurra, Gabriella |
collection | PubMed |
description | Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO’s) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination. |
format | Online Article Text |
id | pubmed-7473829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74738292020-09-08 Tuberculosis in migrants – screening, surveillance and ethics Scandurra, Gabriella Degeling, Chris Douglas, Paul Dobler, Claudia C. Marais, Ben Pneumonia (Nathan) Review Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a ‘silent killer’ because it predominantly affects the poor and marginalized, and disease outbreaks occur in ‘slow motion’ compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO’s) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination. BioMed Central 2020-09-05 /pmc/articles/PMC7473829/ /pubmed/32923311 http://dx.doi.org/10.1186/s41479-020-00072-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Scandurra, Gabriella Degeling, Chris Douglas, Paul Dobler, Claudia C. Marais, Ben Tuberculosis in migrants – screening, surveillance and ethics |
title | Tuberculosis in migrants – screening, surveillance and ethics |
title_full | Tuberculosis in migrants – screening, surveillance and ethics |
title_fullStr | Tuberculosis in migrants – screening, surveillance and ethics |
title_full_unstemmed | Tuberculosis in migrants – screening, surveillance and ethics |
title_short | Tuberculosis in migrants – screening, surveillance and ethics |
title_sort | tuberculosis in migrants – screening, surveillance and ethics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473829/ https://www.ncbi.nlm.nih.gov/pubmed/32923311 http://dx.doi.org/10.1186/s41479-020-00072-5 |
work_keys_str_mv | AT scandurragabriella tuberculosisinmigrantsscreeningsurveillanceandethics AT degelingchris tuberculosisinmigrantsscreeningsurveillanceandethics AT douglaspaul tuberculosisinmigrantsscreeningsurveillanceandethics AT doblerclaudiac tuberculosisinmigrantsscreeningsurveillanceandethics AT maraisben tuberculosisinmigrantsscreeningsurveillanceandethics |